The Extracorporeal Membrane Oxygenation Machine Market is expected to be around US$ 404.45 Million by 2027 at a CAGR of 4.56% in the given forecast period.

Extracorporeal membrane oxygenation is a machine that delivers cardiac and respiratory support for those patients whose lungs and heart are unable to deliver an acceptable supply of gas exchange to the body. It is also known as a life support machine. This technique permits prolonged life support to patients due to the incapability of their organs to make as per the important functioning. The global extracorporeal membrane oxygenation machine market is driven by factors such as the rising prevalence of respiratory diseases and cardiovascular, increasing acceptance of the ECMO machine for lung transplantation, and the growing number of ECMO centers. Moreover, the increasing prevalence of lung diseases coupled with growing geriatric population is anticipated to fuel the market development. The growing number of hospitals offering ECMO services and the growing number of alertness programs are some of the factors improving the market development.

The global Extracorporeal Membrane Oxygenation Machine market is segregated on the basis of Modality as Venoarterial, Venovenous, and Arteriovenous. Based on Application the global Extracorporeal Membrane Oxygenation Machine market is segmented in Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation.

The global Extracorporeal Membrane Oxygenation Machine market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Extracorporeal Membrane Oxygenation Machine market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc., ALung Technologies, Inc., EUROSETS S.r.l, and others are among the major players in the global Extracorporeal Membrane Oxygenation Machine market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Extracorporeal Membrane Oxygenation Machine Market has been segmented as below:

Extracorporeal Membrane Oxygenation Machine Market, By Modality

• Venoarterial
• Venovenous
• Arteriovenous

Extracorporeal Membrane Oxygenation Machine Market, By Application

• Respiratory
• Cardiac
• Extracorporeal Cardiopulmonary Resuscitation

Extracorporeal Membrane Oxygenation Machine Market, By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Extracorporeal Membrane Oxygenation Machine Market, By Company

• Getinge Group
• Medtronic plc
•  LivaNova PLC
• XENIOS AG
• Terumo Corporation
• MicroPort Scientific Corporation
• NIPRO Corporation
• OriGen Biomedical, Inc.
• ALung Technologies, Inc.
• EUROSETS S.r.l

The report covers:

• Global Extracorporeal Membrane Oxygenation Machine market sizes from 2018 to 2027, along with CAGR for 2022-2027
• Market size comparison for 2020 vs 2027, with actual data for 2021, estimates for 2022 and forecast from 2022 to 2027
• Global Extracorporeal Membrane Oxygenation Machine market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Extracorporeal Membrane Oxygenation Machine market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

Report Scope:

The global Extracorporeal Membrane Oxygenation Machine market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Extracorporeal Membrane Oxygenation Machine market share. Major industry players with significant revenue share include Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, Inc., ALung Technologies, Inc., EUROSETS S.r.l, and others.

Reasons to Buy this Report:

• Gain detailed insights on the Extracorporeal Membrane Oxygenation Machine industry trends
• Find complete analysis on the market status
• Identify the Extracorporeal Membrane Oxygenation Machine market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Customization

Customized report as per the requirement can be offered with appropriate recommendations.

Below are our New Reports :-

outdoor LED displays market

Trade Management Software market

Transforming Growth Factor Beta 1 market

Manufacturing Execution System Market

Transparent Conductive Films Market